For research use only
| Cat No. | ABC-TC3121 |
| Product Type | Human Mesenchymal Stem Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Explore HighQC™ Bone Marrow MSC CD105+ Endothelial Cells for hematopoietic niche modeling, endothelial lineage tracing, and angiogenesis research.
HighQC™ Bone Marrow Mesenchymal Stem Cell CD105+ Endothelial Cells are human-derived adherent cells isolated from bone marrow mononuclear cells through positive selection. CD105 (endoglin), a TGF-β receptor family member, is highly expressed on vascular endothelial and mesenchymal stem cells, indicating multipotent capabilities. These cells exhibit fibroblast-like morphology and express MSC-related markers including CD44, CD90, and CD105. Under appropriate conditions, they are capable of differentiating into multiple mesodermal lineages including osteogenic, adipogenic, and chondrogenic cells, making them valuable for vascular biology and regenerative studies.These cells are applicable for modeling osteoarthritis, atherosclerosis, and vascular remodeling in post-infarction or diabetic conditions. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Bone Marrow Mesenchymal Stem Cell CD105+ Endothelial Cells,CD105+ Endothelial Cells,Endothelial Cells,ECs |
| Species | Human |
| Cat.No | ABC-TC3121 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Mesenchymal Stem Cells |
HighQC™ Bone Marrow Mesenchymal Stem Cell CD105+ Endothelial Cells are ideal for modeling angiogenesis, studying vascular remodeling, and investigating endothelial-to-mesenchymal transition (EndMT) in vitro. Their dual endothelial–mesenchymal phenotype makes them suitable for vascular graft engineering and inflammation modulation. Owing to their multilineage differentiation capacity, these cells are used in osteogenesis, adipogenesis, and chondrogenesis studies. Additionally, they provide a physiologically relevant platform for drug screening, wound healing research, and TGF-β pathway–related disease modeling.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).